Ceftriaxone: Clinical Trials

35 trials of Ceftriaxone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 7 unknown, 5 terminated, 1 not yet recruiting. 35 Phase 2, 7 Phase 3, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 235Completed 20, Unknown 7, Terminated 5, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Phase 37Completed 4, Unknown 2, Terminated 1
Phase 13Completed 1, Terminated 1, Unknown 1

Follow Ceftriaxone: new trials by email Literature Review of Ceftriaxone trials Research Report on Ceftriaxone

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial
Sulbactam 25mg/kg -Durlobactam 25mg/kg (Every 6 hours), Ceftriaxone for Injection, Amoxicillin - Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection
Phase 2Not yet recruitingThe University of Queensland3002027-04-012026-03-20
Optimizing the Diagnostic Approach to Cephalosporin Allergy Testing
Beta-lactam antibiotic (cefazolin, cefuroxime, cefotaxime, ceftazidime, ceftriaxone, cefepime, pre-pen, penicillin G, ampicillin, and histamine) double-blind skin testing, Culprit cephalosporin (cefazolin, ceftazidime, ceftriaxone, cefepime, cephalexin, cefaclor, cefadroxil, cefuroxime, cefpodoxime, cefdinir, or cefixime) double-blind placebo-controlled drug challenge, Similar cephalosporin (cefepime, ceftriaxone, cefaclor, cephalexin, cefixime, or cefdinir) antibiotic double-blind placebo-controlled drug challenge - Drug Allergy, Cephalosporin Allergy
Phase 2RecruitingMassachusetts General Hospital3002025-05-052026-11-12
Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)
Piperacillin/tazobactam, Normal saline, CefTRIAXone Injection - Appendicitis Perforated
Phase 2CompletedMcMaster Children's Hospital162024-09-092026-07-07
Prophylactic Antibiotic in Subtalar Fusion Surgery
Ceftriaxone 2000 mg - Surgical Site Infection
Phase 2 / Phase 3UnknownAssiut University1022024-09-012024-07-30
Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria
Ceftriaxone (Rocephin®), Levofloxacin - Urinary Tract Infection (Diagnosis)
Phase 2 / Phase 3CompletedAin Shams University1402024-07-012025-11-17
Antibiotic Instillation in Appendicitis
Ceftriaxone, Intra-peritoneal Fluid Aspiration - Complicated Appendicitis, Acute Appendicitis
Phase 2CompletedJohns Hopkins All Children's Hospital1902023-01-052025-03-13
Tebipenem Trial in Children With Shigellosis
Tebipenem Pivoxil, Azithromycin, Ceftriaxon - Shigellosis
Phase 2CompletedInternational Centre for Diarrhoeal Disease Research, Bangladesh1322022-08-182026-09-01
Propranolol on Post Stroke Immune Status and Infection
Propranolol, Ceftriaxone - Stroke, Cerebrovascular Disorders
Phase 2UnknownTianjin Medical University General Hospital452022-06-012022-05-16
Efficacy of Immunization With 4C-MenB in Preventing Experimental Urethral Infection With Neisseria Gonorrhoeae
Cefixime, Ceftriaxone, Ciprofloxacin - Gonorrhea Male
Phase 2CompletedUniversity of North Carolina, Chapel Hill652022-04-182026-03-02
PROPER Trial of Pain and Inflammation After Knee Arthroscopy
Ceftriaxone, Placebo - Meniscus Tear, Meniscus Lesion
Phase 2TerminatedAustin V Stone52021-12-282023-09-05
Cefuroxime vs Ceftriaxone for SSI Prevention in Neurosurgery
Cefuroxime (Zinnat®), Ceftriaxone (Rocephin®) - Surgical Site Infection, Antibiotics Prophylaxis
Phase 2CompletedDr. Promise Tamunoipiriala Jaja962021-12-012023-05-26
Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)
Standard of care without prophylaxis, Antibiotic prophylaxis - Out-Of-Hospital Cardiac Arrest, Pneumonia
Phase 2TerminatedDavid J. Gagnon532021-08-202025-04-17
Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection
Ceftriaxone 1000mg + doxycycline 100 mg, Cefixime 800mg + doxycycline 100 mg - Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection
Phase 2CompletedHaiphong University of Medicine and Pharmacy1252021-07-152022-03-17
Strategies to Reduce Mortality Among HIV-infected and HIV-exposed Children Admitted With Severe Acute Malnutrition
Ceftriaxone Sodium, Ampicillin, Gentamicin - HIV-1-infection, Malnutrition, Child
Phase 2 / Phase 3UnknownMakerere University3002021-06-142021-09-30
Treatment of Coronavirus COVID-19 Pneumonia (Pathogen SARS-CoV-2) With Cryopreserved Allogeneic P_MMSCs and UC-MMSCs
Placenta-Derived MMSCs; Cryopreserved Placenta-Derived Multipotent Mesenchymal Stromal Cells, Antibiotics, Hormones - COVID-19 Pneumonia
Phase 1 / Phase 2UnknownInstitute of Cell Therapy302020-05-022020-07-08
Combination Antibiotic Therapy Compared to Monotherapy in the Treatment of Acute COPD
Beta-Lactams, Fluoroquinolone - COPD Exacerbation Acute
Phase 2 / Phase 3CompletedHaiphong University of Medicine and Pharmacy1702020-01-012021-05-10
Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
Ceftriaxone, Metronidazole, Placebo infusion - Ulcerative Colitis, Inflammatory Bowel Diseases
Phase 2CompletedPost Graduate Institute of Medical Education and Research, Chandigarh502019-04-012020-12-11
To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia
Ceftriaxone, Placebo - Parkinson's Disease Dementia
Phase 2CompletedBrainX Corporation1002019-02-152026-07-22
Evaluation of an Antibiotic Regimen Pharmacokinetic Applicable to Enterococcus Faecalis Infective Endocarditis
Ceftriaxone 4g/ 24h, Ceftriaxone 2g/ 12h - Infectious Endocarditis
Phase 2CompletedFundación Pública Andaluza para la gestión de la Investigación en Sevilla122018-04-232024-04-03
Optimising Antibiotic Treatment for Sick Malnourished Children
Ceftriaxone, Metronidazole - Malnutrition
Phase 2UnknownUniversity of Oxford812016-04-012017-07-02

Showing 20 of 35. Sign in to see all of them.

Conditions studied

Infections (4)  ·  Appendicitis (2)  ·  Gonorrhea (2)  ·  Pneumonia (2)  ·  Pneumonia, Bacterial (2)  ·  Surgical Wound Infection (2)  ·  Anaphylaxis (1)  ·  Bipolar Disorder (1)  ·  Borrelia Infections (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Child Nutrition Disorders (1)  ·  Cholangitis (1)

Sponsors

Haiphong University of Medicine and Pharmacy (2)  ·  Ain Shams University (1)  ·  Arrevus Inc. (1)  ·  Assiut University (1)  ·  Austin V Stone (1)  ·  BrainX Corporation (1)  ·  Cairo University (1)  ·  David J. Gagnon (1)  ·  Dr. Promise Tamunoipiriala Jaja (1)  ·  Forest Laboratories (1)  ·  Fundación Pública Andaluza para la gestión de la Investigación en Sevilla (1)  ·  Harold Wiesenfeld (1)  ·  Hoffmann-La Roche (1)  ·  Institute of Cell Therapy (1)  ·  International Centre for Diarrhoeal Disease Research, Bangladesh (1)

Countries

United States (15)  ·  Spain (4)  ·  Bulgaria (3)  ·  Canada (3)  ·  Hungary (3)  ·  Argentina (2)  ·  Poland (2)  ·  South Korea (2)  ·  Ukraine (2)  ·  Vietnam (2)  ·  Australia (1)  ·  Bangladesh (1)  ·  Chile (1)  ·  China (1)  ·  Croatia (1)

Top investigators

Amos O Adeleye, FWACS, FACS (1)  ·  Augustine A Adeolu, FWACS (1)  ·  Austin V Stone, MD, PhD (1)  ·  Brian A Fallon, MD (1)  ·  Brian Fallon, M.D. (1)  ·  David A Khan, MD (1)  ·  David Gagnon, PharmD (1)  ·  Harold C Wiesenfeld, MD (1)

Results publications

PMID 25631195, PMID 26229155, PMID 27093162, PMID 27682068, PMID 28052855, PMID 30403954, PMID 32052831, PMID 33245002, PMID 35810277, PMID 35813373, PMID 38022210, PMID 38398427, PMID 40000088, PMID 40086037, PMID 40885534, PMID 41202087, PMID 42049314

NIH funding

2008 (1), P20GM139745 (1), U01AI162457 (1), U01AI184071 (1), U19AI084024 (1)